Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

Home > Science Hub > Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)
Back to the list

July 29, 2020

Maxim Isabelle, Michael Schirm, Gwenaël Pottiez, Rudolf Guilbaud, and Lorella Di Donato

Clinical Proteomics for Patient Stratification – A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE), AACR 2020

Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

Download poster

You might also be interested by

Web News

CellCarta Expands Proteomics Offering with Olink® Reveal Assay

August 6, 2025

Proteomics/Mass Spectrometry

More info

Brochures & Infographics

Supporting Your Targeted Protein Degradation Strategies

April 1, 2025

Proteomics/Mass Spectrometry

More info

Web News

CellCarta Joins Olink™ Certified Service Provider Network in China

February 13, 2025

Proteomics/Mass Spectrometry

More info

Brochures & Infographics

High Performance Technologies for Cytokine Measurement

July 29, 2024

Immune Monitoring

More info